GCMS analysis of Cannabis sativa L. from four different areas of Pakistan

Egyptian Journal of Forensic Sciences

Volumn 5, Issue 3, 2015, Pages 114-125

  Tayyab, Muhammad ^a   Shahwar, Durre ^a  

^a GC UNIVERSITY   (Pakistan)

Author keywords

Cannabis; Chromatogram; GCMS

Indexed keywords

EID: 84965167376     PISSN: 2090536X     EISSN: 20905939     Source Type: Journal    
DOI: 10.1016/j.ejfs.2014.07.008     Document Type: Article

References (10)

1. UNODC, Recommended methods for the identification and analysis of cannabis and cannabis products; 2009.
2. UNODC, World drug report; 2013.
3. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009, 374:1383-1391.
4. European Monitoring Centre for Drugs and Drug Addiction, Cannabis. 2011.
5. Di Forti M., Morgan C., Dazzan P., Pariante C., Mondelli V., Marques T.R., et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009, 195:488-491.
6. Kuepper R., van O.J., Lieb R., Wittchen H.U., Hofler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011, 342:d738.
7. King L.A., Carpentier C., Griffiths P. Cannabis potency in Europe. Addiction 2005, 100:884-886.
8. Pijlman F.T., Rigter S.M., Hoek J., Goldschmidt H.M., Niesink R.J. Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops. Addict Biol 2005, 10:171-180.
9. Cascini F., Aiello C., Di T.G. Increasing delta-9-tetrahydrocannab- inol (delta-9-THC) content in herbal cannabis over time: system- atic review and meta-analysis. Curr Drug Abuse Rev 2012, 5:32-40.
10. Burgdorf J.R., Kilmer B., Pacula R.L. Heterogeneity in the composition of marijuana seized in California. Drug Alcohol Depend 2011, 117:59-61.